Autism
Curemark to Present at the Rodman & Renshaw Global Healthcare
Published in Mental Health Weekly Digest, May 3rd, 2010
Dr. Joan Fallon, Curemark's founder and CEO, will discuss the company's enzyme replacement therapy targeted to autism and other neurological disorders. Curemark is currently in Phase III clinical trials for CM-AT, its autism treatment, which the FDA recently designated as a Fast Track drug.
CM-AT, one of the first therapies to address the underlying physiology of autism, is based on Dr. Fallon's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
More Articles from Mental Health Weekly Digest
- BioMed Central
1 in 10 revelers plan on consuming more than 40 units of alcohol in a single evening - Harvard School of Public Health
Tobacco company's new, dissolvable nicotine products could lead to accidental poisoning - Johns Hopkins University Bloomberg School of Public Health
Fatal injuries increase in older Americans - Kennedy Krieger Institute
Study provides new insights into the implications of autism onset patterns - Penn State
Family caregiving stress filled and isolating - The Mount Sinai Hospital / Mount Sinai School of Medicine
Mount Sinai researchers discover genetic framework to explain and predict adverse drug reactions - More from this issue of Mental Health Weekly Digest
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
